Literature DB >> 23979193

Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates: a 3D-QSAR study.

David Fernández1, Joaquín Ortega-Castro, Juan Frau.   

Abstract

We report the results of a comparative molecular field analysis and comparative molecular similarity index analysis of the human farnesyl pyrophosphate synthase (FPPS) inhibition by nitrogen bisphosphonates (NBPs) taking into account their time-dependent inhibition efficacies. The 3D-QSAR models obtained provide steric, electrostatic and hydrophobic contour maps consistent with the interactions into the active site of human FPPS observed in available crystallographic structures. Furthermore, the 3D-QSAR models obtained provide accurately IC50 values of the NBPs of the training set. The predictive ability of these 3D-QSAR models was found to rely on the choice of biologically active conformations of the target molecules and on a careful examination of the protonation status of the NBPs in the training set. The best models obtained can be useful to predict biological values of a high number of NBPs that have been used for the treatment of different diseases as potential inhibitors of the activity of the FPPS enzyme.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23979193     DOI: 10.1007/s10822-013-9674-2

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  37 in total

1.  Partial least squares modeling and genetic algorithm optimization in quantitative structure-activity relationships.

Authors:  K Hasegawa; K Funatsu
Journal:  SAR QSAR Environ Res       Date:  2000       Impact factor: 3.000

2.  Bisphosphonates for osteoporosis--where do we go from here?

Authors:  Marcea Whitaker; Jia Guo; Theresa Kehoe; George Benson
Journal:  N Engl J Med       Date:  2012-05-09       Impact factor: 91.245

3.  Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma.

Authors:  H Sicard; T Al Saati; G Delsol; J J Fournié
Journal:  Mol Med       Date:  2001-10       Impact factor: 6.354

4.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

5.  Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies.

Authors:  Carlos E Sanz-Rodríguez; Juan L Concepción; Sara Pekerar; Eric Oldfield; Julio A Urbina
Journal:  J Biol Chem       Date:  2007-02-28       Impact factor: 5.157

6.  Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

Authors:  C M Shipman; M J Rogers; J F Apperley; R G Russell; P I Croucher
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

Review 7.  Protein prenylation: molecular mechanisms and functional consequences.

Authors:  F L Zhang; P J Casey
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

Review 8.  Factors associated with osteonecrosis of the jaw among bisphosphonate users.

Authors:  Lisa M Hess; Joanne M Jeter; Marge Benham-Hutchins; David S Alberts
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

9.  A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.

Authors:  Evangelia Kotsikorou; Eric Oldfield
Journal:  J Med Chem       Date:  2003-07-03       Impact factor: 7.446

10.  Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation.

Authors:  Yonghui Zhang; Rong Cao; Fenglin Yin; Michael P Hudock; Rey-Ting Guo; Kilannin Krysiak; Sujoy Mukherjee; Yi-Gui Gao; Howard Robinson; Yongcheng Song; Joo Hwan No; Kyle Bergan; Annette Leon; Lauren Cass; Amanda Goddard; Ting-Kai Chang; Fu-Yang Lin; Ermond Van Beek; Socrates Papapoulos; Andrew H-J Wang; Tadahiko Kubo; Mitsuo Ochi; Dushyant Mukkamala; Eric Oldfield
Journal:  J Am Chem Soc       Date:  2009-04-15       Impact factor: 15.419

View more
  3 in total

1.  New insights into human farnesyl pyrophosphate synthase inhibition by second-generation bisphosphonate drugs.

Authors:  D Fernández; R Ramis; J Ortega-Castro; R Casasnovas; B Vilanova; J Frau
Journal:  J Comput Aided Mol Des       Date:  2017-06-19       Impact factor: 3.686

2.  Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition.

Authors:  David Fernández; Joaquin Ortega-Castro; Laura Mariño; Joan Perelló; Juan Frau
Journal:  J Comput Aided Mol Des       Date:  2015-06-17       Impact factor: 3.686

Review 3.  Role of Metabolism in Bone Development and Homeostasis.

Authors:  Akiko Suzuki; Mina Minamide; Chihiro Iwaya; Kenichi Ogata; Junichi Iwata
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.